FDA Project Focuses On Imaging To Improve Stent Design
This article was originally published in The Gray Sheet
Executive Summary
Research supported by FDA's "critical path" initiative suggests that computed tomography is a useful tool for studying the mechanical dynamics of stents placed in leg arteries, among the more challenging parts of the body for device use
You may also be interested in...
FDA Rounds Up Biliary Stent Makers On Off-label Promotion
FDA gathered biliary stent manufacturers to discuss how to prevent off-label marketing for peripheral vascular disease while it clarifies the regulatory pathway for vascular stents
Imaging Is Key To Product Development In Critical Path Opportunities List
Imaging techniques hold "vast potential" to help speed the development of new medical products, FDA says in the latest report on its Critical Path initiative
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.